KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Aurinia Pharmaceuticals (AUPH) FCF Margin (2018 - 2025)

Historic FCF Margin for Aurinia Pharmaceuticals (AUPH) over the last 10 years, with Q3 2025 value amounting to 60.41%.

  • Aurinia Pharmaceuticals' FCF Margin rose 354100.0% to 60.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 45.1%, marking a year-over-year increase of 323600.0%. This contributed to the annual value of 18.76% for FY2024, which is 382300.0% up from last year.
  • As of Q3 2025, Aurinia Pharmaceuticals' FCF Margin stood at 60.41%, which was up 354100.0% from 63.05% recorded in Q2 2025.
  • In the past 5 years, Aurinia Pharmaceuticals' FCF Margin registered a high of 63.05% during Q2 2025, and its lowest value of 5971.55% during Q1 2021.
  • Its 5-year average for FCF Margin is 375.76%, with a median of 24.16% in 2023.
  • Its FCF Margin has fluctuated over the past 5 years, first crashed by -56848900bps in 2021, then soared by 57550200bps in 2022.
  • Quarter analysis of 5 years shows Aurinia Pharmaceuticals' FCF Margin stood at 110.76% in 2021, then soared by 133bps to 36.28% in 2022, then fell by -14bps to 31.07% in 2023, then surged by 62bps to 50.21% in 2024, then grew by 20bps to 60.41% in 2025.
  • Its FCF Margin was 60.41% in Q3 2025, compared to 63.05% in Q2 2025 and 2.05% in Q1 2025.